🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT03669809
Recruiting Observational

The Biological Rhythm of Human Metabolite

NCT03669809 · tracked via the Priya Life Science China tracker
Sponsor
Shandong Provincial Hospital
Phase
Observational
Started
2011-05-01
Last updated
2022-05-11

Condition(s) studied

Rhythm NodalMetabolism and Nutrition DisorderMetabolism Disorder, Lipid

Study summary

The circadian regulation in mammals have been known for a long time. A special group of clock genes, organized in feedback loops, are responsible for the circadian regulation in both the SCN and peripheral organs. The central clock is mainly entrained by the light-dark cycle, while the peripheral ones in organs such as liver and intestine, are more influenced by the feeding-fasting cycles. The coordination of central and peripheral clocks is thought to be essential in the maintenance of physiological homeostasis.This study aim to investigate the association between biological rhythm and metabolism.

Eligibility

Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Male or female; * Aged of 18 to 30 years old; Exclusion Criteria: * Presence of pituitary/hypothalamic disorders, polycystic ovarian syndrome, thyroid disorders, hypertension, malignant tumor, cardiac insufficiency,hepatic or renal insufficiency, gastrointestinal disorders and acute infection; * Receiving psychotropic or hormonal medications including hormonal contraception and hormone therapies; * Taking lipid-lowering agents or hypoglycemic agents and other drugs that known to influence cardiovascular health; * Pregnancy or lactation women; * Obviously poor compliance.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shandong Provincial Hospital Jinan Shandong Recruiting

More Shandong Provincial Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03669809 on ClinicalTrials.gov ↗ ← All trials in China